Table 1 Comparison of clinical characteristics between diabetic and nondiabetic patients
Non-diabetics (N = 62) | Type 2 diabetics (N = 38) | p value | |
|---|---|---|---|
Age (years)* | 59.8 ± 10.3 | 61.5 ± 11.0 | 0.300 |
Male gender (%) | 90.3 | 89.5 | 0.891 |
BMI (Kg/m2)* | 27.9 ± 4.4 | 29.2 ± 6.9 | 0.251 |
Previous CAD (%) | 14.5 | 31.6 | 0.075 |
Previous MI (%) | 11.3 | 18.4 | 0.319 |
Type of MI | |||
STEMI vs NSTEMI (%) | 66.1/33.9 | 63.2/36.8 | 0.762 |
Cardiovascular risk factors | |||
Hypertension (%) | 56.5 | 84.2 | 0.004 |
Smoking habits (%) | 61.3 | 47.4 | 0.215 |
Family history (%) | 37.1 | 28.9 | 0.492 |
Hyperlipidemia (%) | 71.1 | 82.3 | 0.189 |
Physical inactivity (%) | 56.5 | 60.5 | 0.689 |
Previous cardiovascular or antidiabetic drugs | |||
Statins (%) | 29.0 | 31.6 | 0.825 |
ASA (%) | 19.4 | 42.1 | 0.021 |
ACEI (%) | 12.9 | 36.8 | 0.007 |
ARB (%) | 12.9 | 31.6 | 0.038 |
Beta-blockers (%) | 9.7 | 21.1 | 0.141 |
Insulin (%) | 0.0 | 26.3 | <0.001 |
Oral hypoglycemic (%) | 0.0 | 65.8 | <0.001 |
Baseline laboratory | |||
Admission Troponin I (μg/L)§ | 0.7 ± 5.8 | 1.5 ± 3.6 | 0.798 |
Peak Troponin I (μg/L)§ | 55.4 ± 71.6 | 56.7 ± 64.7 | 0.793 |
HbA1C (%)§ | 5.6 ± 0.5 | 7.1 ± 2.2 | <0.001 |
Admission glycemia (mg/dl)§ | 109.0 ± 31.0 | 206.5 ± 110.8 | <0.001 |
First fasting glycemia (mg/dl)§ | 103.0 ± 24.5 | 156.0 ± 52.5 | <0.001 |
Total cholesterol (mg/dl)* | 178.5 ± 59.0 | 211.7 ± 54.9 | 0.007 |
LDL cholesterol (mg/dl)* | 113.2 ± 39.6 | 145.3 ± 44.3 | <0.001 |
HDL cholesterol (mg/dl)§ | 40.2 ± 9.5 | 38.7 ± 12.9 | 0.164 |
Triglycerides (mg/dl)§ | 138.5 ± 109.5 | 148.0 ± 88.5 | 0.801 |
Uric acid (mg/dl)* | 5.6 ± 1.3 | 6.2 ± 1.4 | 0.096 |
Baseline creatinine (mg/dl)§ | 0.8 ± 0.3 | 0.9 ± 0.4 | 0.123 |
Baseline hemoglobin (g/dl)* | 14.8 ± 1.4 | 14.4 ± 1.2 | 0.200 |
Admission hs-CRP (mg/dl)* | 0.9 ± 1.3 | 1.0 ± 1.4 | 0.872 |
LVEF (%)* | 52.6 ± 9.6 | 50.0 ± 11.8 | 0.104 |
Hospital length of stay§ | 5.4 ± 2.6 | 5.9 ± 3.0 | 0.424 |